OMNOVA Solutions — Q1 2019 Earnings Presentation
32 slides from OMNOVA Solutions's earnings presentation, Mar 27, 2019
Slide 1: Investor Presentation – First Quarter 2019
Exhibit 99.2 Global Innovator of Performance-Enhancing Chemistries and Surfaces Investor Presentation – First Quarter 2019 NYSE LISTED: “OMN”
Slide 2: Cautionary Statements
Cautionary Statements › Forward Looking Statements This presentation includes descriptions of OMNOVA's current business, operations, assets and other matters affecting the Company as well as "forward-looking statements" as defined by federal securities laws. All forward-looking statements by the Com
Slide 3: About OMNOVA Solutions
About OMNOVA Solutions › Global technology-based supplier of customized performance-critical products › Established in 1999; formerly part of General Tire/GenCorp and Goodyear › Deep focus on Research and Development (R&D) and Innovation across all our businesses › Diverse end-markets that value inn
Slide 4: Our Vision and Values
Our Vision and Values To be a mid-sized premier global specialties provider delivering innovative, tailored solutions to win leading positions in targeted high value markets. Safety Agility We promote a safety-first culture We swiftly and efficiently adapt to PRODUCE PRODUCT SAFELY – and changing en
Slide 5: Long Heritage as Solutions Provider
Long Heritage as Solutions Provider › More than a century of Transformation and Innovation CHEMICAL/PLASTICS * DIVISION 1915 1952 1984 1999 2018 1898 1941 2001 2010 2015 2017 THE GOODYEAR TIRE & GOODYEAR CHEMICALS NEW FLUID CREOLE RUBBER COMPANY SOLUTIONS CHEMICALS * Announced September 26, 2018. 5
Slide 6: OMNOVA Locations
OMNOVA Locations Beachwood, OH (Headquarters) Akron, OH (Technology Center) Green Bay, WI Mogadore/Akron, OH Fitchburg, MA London, U.K. Auburn, PA Jeannette, PA Caojing, China Le Havre, France Monroe, NC Villejust, France Shanghai (Regional HQ) (Regional HQ) Chester, SC Sintra, Portugal Ningbo, Chin
Slide 7: OMNOVA at a Glance
OMNOVA at a Glance LTM Sales: $760M Sales by segment LTM Adj. EBITDA: $78M* Adj. EBITDA Margin: 10.3%* Performance Materials 35% Specialty Solutions Performance Materials LTM Sales: $491M LTM Sales: $269M Specialty Solutions LTM Adj. EBITDA: $87M* LTM Adj. EBITDA: $15M* 65% Adj. EBITDA margin: 17.7%
Slide 8: Goals Reflect Continuing Transition to Specialty Focus
Goals Reflect Continuing Transition to Specialty Focus Growth: Adjusted Segment GDP+ Underlying Specialty Markets Operating Margin* High 0 Mid › Specialty Volume Growth Teens › High Margin New Product Introductions 10.6% › Commercial Excellence 6.9% › Cost Reductions › Value Based Pricing of Technol
Slide 9: Our Value-Creating Overarching Strategic Priorities
Our Value-Creating Overarching Strategic Priorities Expand Margins, Accelerate Generate Cash Growth In In Mature Specialty Businesses Businesses “One OMNOVA” Portfolio Excellence Optimization 9 INVESTOR PRESENTATION | First Quarter 2019 NYSE OMN
Slide 10: Accelerate Growth in Specialty Businesses
Accelerate Growth in Specialty Businesses Strengthening Commercial Excellence › Integrated sales, marketing and product development › Cross-selling >80% › Value based pricing › Aggressive strategic marketing plans of revenue › Stronger key account value added selling targeted from specialty Strong,
Slide 11: Specialty Growth: Targeted Markets
Specialty Growth: Targeted Markets › Targeting robust markets with demand for high performance, high margin products C.A.S.E Coatings Adhesives Sealants Elastomers Laminates Nonwovens Oil & Gas › Masonry › Tapes › Caulking › Transportation › Retail Display › Diapers › Drilling › Intumescent (fire ›
Slide 12: Diversifying Chemistries & Geographies
Diversifying Chemistries & Geographies › Increased access to specialty markets Diversifying Chemistries Total OMNOVA and Markets Global Expansion 2% 11% 15%11% Asia Other 20% Chemistries 24% Europe 73% 87% 87% N. America SB Latex 80% 61% 27% Pre-2010 2018 Pre-2010 2018 Total Company Total Company 12
Slide 13: New Product Introductions
New Product Introductions › Transforming the portfolio to be a leading provider of Sustainable, Greener, SMARTer innovative solutions Recently Introduced New Products Pliotec LEB20 – Unique water-based resin GenFlo – Binder for Softer Personal for exterior masonry paints excellent color Hygiene
Slide 14: Expand Margins, Increase Cash Generation in Performance Materials
Expand Margins, Increase Cash Generation in Performance Materials Businesses Strengthening Customer Relationships › Value-based pricing › Capture growth in carpet and non-carpet flooring › Working capital optimization Expand and grow margins Exited Commodity Paper in 2018 Increase cash generation ›
Slide 15: Performance Materials Manufacturing Realignment and SG&A Restructuring
Performance Materials Manufacturing Realignment and SG&A Restructuring 2015 – 2017: 2018 – 2019 : › Realigned Manufacturing Footprint › Closure of Green Bay Plant through facility closures, capacity expected by 2H 2019. $7 – 8 million of segment reductions, and manufacturing operating profit benefit
Slide 16: Portfolio Optimization
Portfolio Optimization M&A 1. Close-in › Emulsion polymers › Consolidation opportunities 2. Adjacencies Balanced › Market driven specialty portfolio . C.A.S.E. . Nonwovens Sustainable earnings . Oil & gas growth Strategic Alliances › Joint development & › Lower investment risk licensing agreements ›
Slide 17: Strategic Alliances and M&A to Accelerate Specialty Growth
Strategic Alliances and M&A to Accelerate Specialty Growth STRATEGIC ALLIANCES M&A BENEFITS: › Joint development TechnologyTechnology agreements Close-In › Profitable growth › License technology and minimal risk Emulsion Polymers › Accelerates › N.A. SB consolidation innovation › Geographic swaps /
Slide 18: “One OMNOVA” Excellence
“One OMNOVA” Excellence Excellence Focus Agile, strong › Sales foundation to drive › Innovation profitable growth › Marketing › Operations Reduced Complexity › Common processes, tools and systems › Reduced SG&A >$3M /yr › Organizational redesign › Cost competitive manufacturing Reporting Segment Ali
Slide 19: Adjusted Segment Operating Profit and Adjusted EPS
Adjusted Segment Operating Profit and Adjusted Earnings Per Share (EPS) Adjusted Segment Operating Profit* Adjusted EPS* $0.63 $81.3 PM 8.9% OPM 10.6% $0.28 $68.4 OPM 6.9% 2014 2018 2014 2018 * Non-GAAP adjusted values, GAAP reconciliation in the Appendix. Strategic Actions Driving Improvement in Pr
Slide 20: Record of Cash Generation and De-Leveraging
Record of Cash Generation and De-Leveraging 20% Specialty Sales Growth Due to Volume YOY 16.1% 15% 10% 8.0% 6.7% 5.1% 5% 2.4% 2.0% 1.8% Volume growth 1.1% 1.0% › Gaining traction on specialty growth 0% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 2017 2017 3017 2017 2018 2018 2018 2018 2019 Refinancing completed in Q
Slide 21: Capital Structure / Liquidity / Net Leverage
Capital Structure / Liquidity / Net Leverage › As of February 28, 2019 (in millions) DEBT = $328* Liquidity Revolver $76 Debt & Other › Balance Drawn $11 › Capital lease › Letters of Credit $0 › Letters of credit $27 Remaining Capacity $65 › Revolver ($11M) Cash $34 Total Liquidity $99 Term Loan B N
Slide 22: Goal: Become a Premier Global Innovative Specialty Solutions Provider
Goal: Become a Premier Global Innovative Specialty Solutions Provider Specialty Growth › Marketing, Innovation and Sales Excellence › First to market with differentiated, high margin new products › Key account growth › Geographic expansion Continued focus on operational excellence, delivered margin
Slide 23: Appendix
Appendix › SB Raw Material Costs and Performance Features › Non-GAAP Financial Measures › Reconciliations
Slide 24: SB Raw Material Costs and Performance Features Contribute to Cost-in-Use Advantage
SB Raw Material Costs and Performance Features Contribute to Greater Cost-in-Use Advantage With the recent price drop, SB Latex maintains an Advantaged Position 24 INVESTOR PRESENTATION | First Quarter 2019 NYSE OMN
Slide 25: Appendix – Non-GAAP Financial Measures
Appendix – Non-GAAP Financial Measures This presentation includes Adjusted Segment Operating Profit, Adjusted Segment EBITDA, Adjusted Income from Continuing Operations Before Income Taxes, Adjusted Consolidated EBITDA and other financial measures which are Non-GAAP financial measures as defined by
Slide 26: Reconciliation of Reported Segment Sales and Operating Profit
Appendix 1 ̶ Reconciliation of Reported Segment Sales and Operating Profit to Net Sales and Net Income Three Months Ended February 28, (In millions) 2019 2018 Net Sales: Specialty Solutions $ 112.7 $ 109.2 Performance Materials 56.2 69.5 Total Net Sales 168.9 178.7 Segment Operating Profit: Specialt
Slide 27: OMNOVA Consolidated Adjusted EBITDA
Appendix 2 ̶ OMNOVA Consolidated Adjusted EBITDA Year Ended November 30, LTM* (Dollars in millions except per share data) 2015 2016 2017 2018 2019 Sales $ 838.0 $ 759.9 $ 783.1 $ 769.8 $ 760.0 Unadjusted Segment Operating Profit $ 34.8 $ 68.3 $ 47.3 $ 60.9 $ 51.6 Segment Excluded Items Restructuring
Slide 28: OMNOVA Consolidated Adjusted EBITDA (continued)
Appendix 2 ̶ OMNOVA Consolidated Adjusted EBITDA (continued) Year Ended November 30, LTM* (Dollars in millions except per share data) 2015 2016 2017 2018 2019 Corporate Expense (27.6) (33.7) (29.9) (27.1) (25.5) Interest expense (28.3) (24.7) (21.5) (19.3) (19.2) Corporate Excluded Items Restructuri
Slide 29: OMNOVA Consolidated Adjusted EBITDA (continued)
Appendix 2 ̶ OMNOVA Consolidated Adjusted EBITDA (continued) Year Ended November 30, LTM* (Dollars in millions except per share data) 2015 2016 2017 2018 2019 Adjusted Income from Continuing Operations before Income Taxes $ 23.5 $ 31.7 $ 35.5 $ 38.0 $ 29.5 Unallocated corporate interest (excluding d
Slide 30: OMNOVA Trailing Twelve Months Ended February 2019
Appendix 3 ̶ OMNOVA Trailing Twelve Months Ended February 28, 2019 Specialty Performance Combined (In millions except per share data) Solutions Materials Segments Corporate Consolidated Net Sales $ 491.2 $ 268.8 $ 760.0 $ — $ 760.0 Segment Operating Profit / Corporate Expense $ 66.3 $ (14.7) $ 51.6
Slide 31: OMNOVA Trailing Twelve Months Ended February 2019 (continued)
Appendix 3 ̶ OMNOVA Trailing Twelve Months Ended February 28, 2019 (continued) Specialty Performance Combined (In millions except per share data) Solutions Materials Segments Corporate Consolidated Adjusted Segment Operating Profit as a % of Sales 14.0 % 1.4 % 9.6 % Segment / Corporate Capital Expen
Slide 32: Investor Relations Contacts
Investor Relations Contacts Paul DeSantis, Senior Vice President, Chief Financial Officer & Treasurer Frank Esposito, Corporate Secretary and Investor Relations (216) 682-7003 [email protected] World Headquarters 25435 Harvard Road Beachwood, OH 44122 (216) 682-7000 www.omnova.com INVESTOR PRESENTATION